Clinical Trials Logo

Clinical Trial Summary

Rheumatoid arthritis (RA) is one of the most common autoimmune rheumatic diseases, affecting one in 100 individuals worldwide. It is considered a complex systemic multifactorial inflammatory process in which the immune system targets synovial joints and causes mild to severe joint destruction with extra-articular manifestations. If left untreated, RA leads to deformity, considerable disability, and major comorbid conditions, including cardiovascular disease and increased mortality. Early treatment with targeted therapies can alter long-term outcomes by minimizing disease activity, preventing joint damage and disability, and improving patients' quality of life.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05158400
Study type Interventional
Source Sohag University
Contact Fady B A, resident
Phone 01091799614
Email fady011123@med.sohag.edu.eg
Status Not yet recruiting
Phase N/A
Start date December 15, 2021
Completion date March 15, 2022